A Phase I Bayesian Adaptive Design to Simultaneously Optimize Dose and Schedule Assignments Both Between and Within Patients (Q2861803)

From MaRDI portal
Revision as of 10:10, 29 January 2024 by Daniel (talk | contribs) (‎Created claim: Wikidata QID (P12): Q37291757, #quickstatements; #temporary_batch_1706518640034)
scientific article
Language Label Description Also known as
English
A Phase I Bayesian Adaptive Design to Simultaneously Optimize Dose and Schedule Assignments Both Between and Within Patients
scientific article

    Statements

    A Phase I Bayesian Adaptive Design to Simultaneously Optimize Dose and Schedule Assignments Both Between and Within Patients (English)
    0 references
    0 references
    0 references
    11 November 2013
    0 references
    Bayesian statistics
    0 references
    clinical trial
    0 references
    dose-escalation study
    0 references
    dynamic treatment regime
    0 references
    nonmixture cure model
    0 references

    Identifiers